本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

72.68
-1.7100-2.30%
盤後72.890.2115+0.29%19:52 EDT
成交量:408.26萬
成交額:3.01億
市值:94.70億
市盈率:-123.53
高:77.87
開:74.50
低:71.44
收:74.39
52周最高:77.87
52周最低:11.16
股本:1.30億
流通股本:1.18億
量比:1.53
換手率:3.46%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
淨資產收益率:-9.40%
總資產收益率:-5.05%
市淨率:11.47
市盈率(LYR):-208.22

資料載入中...

2021/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/10/05

重要事件披露

8-K - Current report
2020/09/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report